![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Karolinska Development Ab | LSE:0P3C | London | Ordinary Share | SE0002190926 | KAROLINSKA DEVELOPMENT B ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.00% | 6.50 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 2.01M | 5.39M | 0.0201 | 323.38 | 1.74B |
Date | Time | Source | Headline |
---|---|---|---|
16/7/2024 | 15:49 | UKREG | Karolinska Development’s portfolio company PharmNovo receives EUR 17.5.. |
10/7/2024 | 07:50 | UKREG | Karolinska Development’s portfolio company Umecrine Cognition secures.. |
12/6/2024 | 11:34 | UKREG | Karolinska Development’s portfolio company Biosergen gets final approval to.. |
28/5/2024 | 07:00 | UKREG | Karolinska Development invests in BOOST Pharma, expanding its portfolio |
16/5/2024 | 15:40 | UKREG | Karolinska Development’s Annual General Meeting 2024 |
08/5/2024 | 08:30 | UKREG | Karolinska Development’s portfolio company Umecrine Cognition initiates.. |
26/4/2024 | 07:00 | UKREG | Interim Report - January-March 2024 |
16/4/2024 | 07:00 | UKREG | Notice of Annual General Meeting in Karolinska Development AB (publ) |
22/3/2024 | 08:30 | UKREG | Karolinska Development’s portfolio company Umecrine Cognition presents.. |
22/3/2024 | 07:00 | UKREG | Karolinska Development Annual Report 2023 published |
1 Year Karolinska Development Ab Chart |
Intraday Karolinska Development Ab Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions